Sol-Gel Technologies Ltd. Share Price

Sol-Gel Technologies Ltd. Share Price

NASDAQ: SLGL
$67.60
-$2.72 (-3.87%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sol-Gel Technologies Ltd. Stock Performance

Open
$65.83
Prev. Close
$70.32
Circuit Range
N/A
Day Range
$65.83 - $67.17
Year Range
$31.50 - $90.00
Volume
1,023
Average Traded
$66.51

Sol-Gel Technologies Ltd. Share Price Today

As of 29 October 2026, Sol-Gel Technologies Ltd.'s share price is $67.60. The stock opened at $65.83, compared to its previous close of $70.32. During today's trading session, Sol-Gel Technologies Ltd.'s share price traded between $65.83 and $67.17, with an average price of $66.50. Over the past 52 weeks, the stock has recorded a high of $90.00 and a low of $31.50. In terms of performance, Sol-Gel Technologies Ltd.'s share price has declined by 0.95% over the last six months and is up 88.25% on a year-on-year basis.

Sol-Gel Technologies Ltd. Share Price Chart

Line chart of the Sol-Gel Technologies Ltd. price trend over the selected period. The price fell overall, ranging from 68.00 to 69.89, ending at 68.00.
$65.83$67.17
L
Show Current Price
H

Sol-Gel Technologies Ltd. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$19.39B
Return On Equity (TTM)
N/A
Profit Margin
-31.61%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Sol-Gel Technologies Ltd. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.88$1.55$11.54$19.39
Net Profit-$14.92-$27.24-$10.58-$6.13
Net Profit Margin-384.54%-1757.42%-91.68%-31.61%
Income ChangeN/A-82.57%61.16%42.06%

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Sol-Gel Technologies Ltd. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$70.75
$67.17
-11.03%
Sep 2026
$70.42
$75.50
+2.22%
Aug 2026
$82.85
$73.86
-11.52%
Jul 2026
$72.81
$83.48
+10.06%
Jun 2026
$70.71
$75.85
-4.09%
May 2026
$75.31
$79.08
+15.88%
Apr 2026
$82.50
$68.25
-13.93%
Mar 2026
$89.64
$79.30
-11.89%
Feb 2026
$62.50
$90.00
+43.54%
Jan 2026
$43.65
$62.70
+49.96%
Dec 2025
$36.95
$41.81
+6.13%
Nov 2025
$31.55
$39.40
+9.70%

SLGL Share Price FAQs